Effient ‘unlikely’ to takeover from Plavix

pharmafile | July 23, 2009 | News story | Research and Development, Sales and Marketing Effient, cv 

Related Content

Januvia image

Merck diabetes drug gets CV trial boost

Merck’s diabetes drug Januvia has been given a boost following worries over side effects for …

Lilly image

Lilly’s Efient tipped for expanded NICE approval

 Eli Lilly’s anti-platelet drug Efient has been given the nod by UK healthcare watchdog NICE …

AstraZeneca’s Brilinta delayed

AstraZeneca’s blood thinning drug Brilinta faces an extra three month delay to its review by …

Latest content